Tyrvaya 0.03 mg varenicline per spray (0.05 mL) Images
Generic Name: varenicline
This medication has been identified as Tyrvaya 0.03 mg varenicline per spray (0.05 mL). It is supplied by Oyster Point Pharma.
Tyrvaya is used in the treatment of Dry Eye Disease and belongs to the drug class cholinergic agonists. Risk cannot be ruled out during pregnancy. Tyrvaya 0.03 mg varenicline per spray (0.05 mL) is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Tyrvaya
- Generic Name
- varenicline
- Strength
- 0.03 mg varenicline per spray (0.05 mL)
- Availability
- Prescription only
- Drug Class
- Cholinergic agonists
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Oyster Point Pharma
- National Drug Code (NDC)
- 73521-0030
See also:
Restasis
Restasis is used to treat chronic dry eye that may be caused by inflammation. Learn about side ...
Chantix
Chantix is a smoking cessation medicine used with behavior modification and counseling to help you ...
Caplyta
Caplyta is used to treat schizophrenia or depression associated with bipolar disorder. It is taken ...
Xiidra
Xiidra (lifitegrast 5%) is an eye drop solution that is used twice daily in each eye to treat the ...
Miebo
Miebo (perfluorohexyloctane) is used to treat the signs and symptoms of dry eye disease. Includes ...
Cequa
Cequa (cyclosporine ophthalmic) is a prescription eye drop used to treat chronic dry eye from ...
Lotemax
Lotemax and Lotemax SM (loteprednol etabonate) are corticosteroid medications used to help treat ...
More about Tyrvaya (varenicline)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (45)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: cholinergic agonists
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.